Eupraxia Pharmaceuticals Inc 's ROA from the fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Eupraxia Pharmaceuticals Inc 's ROA in the fourth quarter of 2025?
Eupraxia Pharmaceuticals Inc recorded a cumulative net loss of $-39 million during 12 months ending in the fourth quarter of 2025, resulting in a negative return on assets (ROA) of -44.14%.

However, within the Healthcare sector 607 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2025 from to 4530.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Dec 31 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2024) IV. Quarter
Y / Y Total Assets Change	137.75 %	146.55 %	146.55 %	146.55 %	71.16 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-39	-26	-26	-26	-26
Return On Assets (TTM)	-44.14 %	-34.69 %	-41.92 %	-52.95 %	-71.88 %
EPRX's Total Ranking	# 4530	#	#	#	# 5055
Total Assets (TTM) in million	91	86	86	86	38
Seq. Total Assets Change	6.07 %	0 %	0 %	124.15 %	9.99 %
Seq. Net Income Change	-	-	-	-	-

EPRX's 5 Years Annual ROA >> Back to EPRX Management Effectiveness >> Compare EPRX ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 256
Sector	# 608
Overall	# 4490

Return On Assets Statistics
High	Average	Low
-44.81 %	-59.24 %	-73.68 %
(Dec 31 2025)		(Dec 31 2024)

Financial Statements
Eupraxia Pharmaceuticals Inc 's Assets	$ 91 million	EPRX's Balance sheet
Eupraxia Pharmaceuticals Inc 's Income	$ -39 million	Quarterly EPRX's Income Statement
EPRX's Income by Division		See EPRX's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2022) FY 2023	FY	FY
Y / Y Total Assets Change	137.75 %	71.16 %	-	-	-
Total Assets in million	91	38	22	0	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-39	-26	-29	0	0
Annual Return On Assets	-42.25 %	-66.98 %	-129 %	-	-

EPRX's 5 Years Annual ROA >> Back to EPRX Management Effectiveness >> Compare EPRX ROA to its Competitors

More Return On Assets Ratios
EPRX's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
EPRX's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for EPRX's Competitors
Subscribers only: Roa for Eupraxia Pharmaceuticals Inc 's Suppliers
Subscribers only: Return On Assets for EPRX's Customers

You may also want to know
EPRX's Roi	EPRX's Inventory Turnover Ratio	EPRX's Growth Rates	EPRX's Dividend Comparisons
	EPRX's Profitability Ratios	EPRX's Asset Turnover Ratio	EPRX's Dividend Growth
EPRX's Roe	EPRX's Valuation Ratios	EPRX's Financial Strength Ratios	EPRX's Dividend Payout Ratio

Companies with similar Return On Assets at Dec 31 2025, within Healthcare Sector

ROA

Date modified: 2026-07-07T10:40:17+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.